Dr. Ari Hakimi highlighted how tumor profiling and molecular markers are expanding access to precision-based trials for kidney cancer.
Dr. Ari Hakimi
Advertisement
Dr. Ari Hakimi is a surgeon and researcher at Memorial Sloan Kettering Cancer Center,
Articles by Dr. Ari Hakimi
Advertisement
